ICAM1 and Alzheimer disease: Moreover, inflammatory cytokines and lymphocytes entering the brain through the blood–brain barrier (BBB) can also trigger an inflammatory response in AD patients, and these pathological mechanisms are likely related to the effects of intercellular adhesion molecule-1 (ICAM-1) (Minogue et al., 2014; Solberg et al., 2014).